Oculis Holding AG (OCS) Total Current Liabilities (2021 - 2026)

Oculis Holding AG (OCS) recorded quarterly Total Current Liabilities of $56.0 million in Q1 2026, up 21.83% quarter-over-quarter from $46.0 million in Q4 2025, and up 27.65% on a YoY basis from $43.9 million in Q1 2025.

Oculis Holding AG (OCS) Total Current Liabilities (2021 - 2026) Analysis & Trends

Oculis Holding AG's Total Current Liabilities history runs 6 years deep, the most recent figure standing at $56.0 million for Q1 2026.

  • In Q1 2026, Total Current Liabilities rose 27.65% year-over-year to $56.0 million; the TTM figure through Mar 2026 stood at $56.0 million (up 27.65% YoY), while the FY2025 annual figure was $46.0 million, down 8.95% from the prior year.
  • Total Current Liabilities was $56.0 million for Q1 2026 at Oculis Holding AG, up from $46.0 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $56.0 million in Q1 2026 to a low of $12.5 million in Q4 2022.
  • Historically, Total Current Liabilities has averaged $33.8 million across 5 years, with a median of $32.0 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Total Current Liabilities soared 183.23% in 2022, then fell 8.95% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $12.5 million in 2022, then surged by 72.47% to $21.5 million in 2023, then jumped by 134.65% to $50.5 million in 2024, then retreated by 8.95% to $46.0 million in 2025, then climbed by 21.83% to $56.0 million in 2026.
  • The last three Total Current Liabilities figures came in at $56.0 million (Q1 2026), $46.0 million (Q4 2025), and $42.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Alterity Therapeutics 860,679.92 Bn 860,679.89 Bn - 1.70 Mn
2 Belite Bio 55,284.00 Bn 55,284.00 Bn - -
3 Quantum Biopharma 16,206.94 Bn 16,206.93 Bn - 16.35 Mn
4 Legend Biotech 3,318.00 Bn 3,317.71 Bn 242.10 Mn 636.40 Mn
5 Akari Therapeutics 1,543.84 Bn 1,543.84 Bn - 13.42 Mn
6 Evaxion A 1,449.11 Bn 1,449.09 Bn - -
7 Psyence Biomedical 216.99 Bn 216.98 Bn - -
8 Vertex Pharmaceuticals 115.22 Bn 107.97 Bn 2.59 Bn 3.88 Bn
9 Abivax 90.58 Bn 90.58 Bn - 72.86 Mn
10 Oculis Holding AG 8.45 Bn 8.15 Bn - 56.01 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 56.01 Mn
Dec 31, 2025 45.98 Mn
Sep 30, 2025 42.16 Mn
Jun 30, 2025 44.14 Mn
Mar 31, 2025 43.88 Mn
Dec 31, 2024 50.50 Mn
Sep 30, 2024 31.99 Mn
Jun 30, 2024 26.13 Mn
Mar 31, 2024 20.80 Mn
Dec 31, 2023 21.52 Mn
Sep 30, 2023 25.08 Mn
Jun 30, 2023 18.69 Mn
Dec 31, 2022 12.48 Mn
Dec 31, 2021 4.41 Mn